XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.3
BASIS OF PRESENTATION - Schedule of Revision of Previously Issued Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Total revenue $ 86,106 $ 84,700 $ 259,043 $ 254,416
Operating income 4,068 2,814 15,855 76
Income (loss) before taxes 1,352 (1,595) 6,971 (11,133)
Provision for income taxes (4,250) 7,553 (1,670) 4,257
Net income (loss) $ 5,602 $ (9,148) $ 8,641 $ (15,390)
Net income (loss) per share - basic (in dollars per share) $ 0.37 $ (0.61) $ 0.58 $ (1.04)
Net income (loss) per share - diluted (in dollars per share) $ 0.37 $ (0.61) $ 0.58 $ (1.04)
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss) $ 5,484 $ (9,149) $ 8,505 $ (15,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   (755) (14,952) 5,487
Beginning balance 173,173 179,780 168,695 183,973
Accumulated earnings (deficit) ending balance (6,311) (9,903) (6,311) (9,903)
Ending balance 180,358 171,986 180,358 171,986
Condensed Consolidated Statement of Cash Flows        
Accounts receivable     (4,317) 336
Income taxes, net     (8,453) 282
Financial Health        
Revenue:        
Total revenue 54,501 54,672 164,918 162,620
Patient Care        
Revenue:        
Total revenue $ 31,605 30,028 $ 94,125 91,796
As previously reported        
Revenue:        
Total revenue   83,830   251,806
Operating income   1,944   (2,534)
Income (loss) before taxes   (2,465)   (13,743)
Provision for income taxes   7,344   3,631
Net income (loss)   $ (9,809)   $ (17,374)
Net income (loss) per share - basic (in dollars per share)   $ (0.66)   $ (1.17)
Net income (loss) per share - diluted (in dollars per share)   $ (0.66)   $ (1.17)
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss)   $ (9,810)   $ (17,267)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   567   8,132
Beginning balance   181,102   186,618
Accumulated earnings (deficit) ending balance   (9,242)   (9,242)
Ending balance   172,647   172,647
Condensed Consolidated Statement of Cash Flows        
Accounts receivable       2,946
Income taxes, net       (344)
As previously reported | Financial Health        
Revenue:        
Total revenue   54,271   161,417
As previously reported | Patient Care        
Revenue:        
Total revenue   29,559   90,389
Impact of revision        
Revenue:        
Total revenue   870   2,610
Operating income   870   2,610
Income (loss) before taxes   870   2,610
Provision for income taxes   209   626
Net income (loss)   $ 661   $ 1,984
Net income (loss) per share - basic (in dollars per share)   $ 0.05   $ 0.13
Net income (loss) per share - diluted (in dollars per share)   $ 0.05   $ 0.13
Condensed Consolidated Statement of Comprehensive Income (Loss)        
Comprehensive income (loss)   $ 661   $ 1,984
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accumulated earnings (deficit) beginning balance   (1,322)   (2,645)
Beginning balance   (1,322)   (2,645)
Accumulated earnings (deficit) ending balance   (661)   (661)
Ending balance   (661)   (661)
Condensed Consolidated Statement of Cash Flows        
Accounts receivable       (2,610)
Income taxes, net       626
Impact of revision | Financial Health        
Revenue:        
Total revenue   401   1,203
Impact of revision | Patient Care        
Revenue:        
Total revenue   $ 469   $ 1,407